ABBVIE INC. Stock Prediction
AI-powered sentiment analysis and prediction trends for ABBV, updated each market day.
ABBV AI Sentiment
AI sees no strong directional signal for ABBVIE INC. stock over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Sector
Exchange
Market Cap
$466,554,305,585
Cap Tier
Employees
57,000
Headquarters
NORTH CHICAGO, IL
Listed Since
Dec. 10, 2012
Website
ABBV Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ABBV Volatility
ABBVIE INC. has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
